A study published in PLoS ONE today addresses the impact of neuroprotection on Alzheimer's disease.
Remarkably, the study shows that even very modest neuroprotective effects at the cellular level can lead to dramatic reductions in the number of cases of Alzheimer's.
Based on data derived from 26 epidemiological studies worldwide (comprising over 60,000 subjects), Dr de la Fuente-Fernandez developed a simple mathematical model that will allow researchers to test the effect of new neuroprotective drugs.
Perhaps not too surprisingly, the study suggests however that the most effective neuroprotective therapy for Alzheimer's disease may well not be a pill, but education and intellectual activity. Mounting evidence accumulated over the last few years supports the notion that intellectual activity increases what neuroscientists call "the cognitive reserve".
According to the model, a mere 5% increase in the cognitive reserve in the general population would prevent one third of Alzheimer's cases.
Dr de la Fuente-Fernandez, a neurologist at the Hospital A. Marcide in Ferrol (Spain), points out that public health policies aimed at implementing higher levels of education in the general population are likely the best strategy for preventing Alzheimer's disease.
Source: Public Library of Science
Related stories:
Signs of Alzheimer's disease may be present decades before diagnosis
Scientists from the University of South Florida and the University of Kentucky report that people who develop Alzheimer's disease may show signs of this illness many decades earlier in life, including compromised educational achievement. Their research appears online this month in the journal
Alzheimer's Disease and Associated Disorders.
New criterion may improve identification of dementia risk in highly educated older adults
A different cutoff point on an existing mental function assessment may more effectively assess the risk of dementia in highly educated older adults, according to a report in the July issue of
Archives of Neurology.
Green tea compounds beat OSA-related brain deficits
Chemicals found in green tea may be able to stave off the cognitive deficits that occur with obstructive sleep apnea (OSA), according to a new study published in the second issue for May of the American Thoracic Society’s
American Journal of Respiratory and Critical Care Medicine.
Memory lane: Older persons with more schooling spend fewer years with cognitive loss
Those with at least a high school education spend more of their older years without cognitive loss – including the effects of Alzheimer’s, Parkinson’s and dementia -- but die sooner after the loss becomes apparent, reveals a new study appearing in the June 2008 issue of the
Journal of Aging and Health.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.
Wine may protect against dementia
There may be constituents in wine that protect against dementia. This is shown in research from the Sahlgrenska Academy at University of Gothenburg in Sweden.
Diabetes in mid-life linked to increased risk of Alzheimer's disease
Men who develop diabetes in mid-life appear to significantly increase their risk of developing Alzheimer’s disease, according to a long-term study published in the April 9, 2008, online issue of
Neurology, the medical journal of the American Academy of Neurology.
New research shows neuroprotective effect of lovastatin
High cholesterol levels are considered to be a risk factor for cardiovascular disease including stroke. Therefore, many cholesterol lowering drugs have been developed by pharmaceutical companies in recent years. One class of these drugs, statins, has been found to reduce the incidence of stroke and progression of Alzheimer’s disease when prophylactically administered.